{"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:d4db6a48-e521-4ba5-8c8a-e7bcee1c647a", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-10-08T10:39:59.001500Z", "firstcreated": "2026-10-08T05:33:43.746289Z", "pubstatus": "usable", "urgency": 5, "language": "it", "headline": "Tumore del pancreas, AIOM chiede l'uso compassionevole del daraxonrasib", "byline": "Alessia Amato", "located": "Italy", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Ascensio", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Ascensio”. Set rel=canonical to https://ascensio.uno/societa/tumore-del-pancreas-aiom-chiede-l-uso-compassionevole-del-daraxonrasib/ when publishing on the web.", "description_text": "Il farmaco approvato dalla FDA negli Stati Uniti non è ancora disponibile in Italia. L'AIOM sollecita l'avvio immediato del programma di uso compassionevole per i pazienti con neoplasia metastatica già trattati.", "altids": {"mosaic": "d4db6a48-e521-4ba5-8c8a-e7bcee1c647a", "story": "6739b234-ac65-483b-bb06-337750f8d620", "slug": "tumore-del-pancreas-aiom-chiede-l-uso-compassionevole-del-daraxonrasib"}, "subject": [{"name": "Society", "rel": "direct", "literal": "society", "code": "medtop:14000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/14000000"}], "place": [{"name": "Italy", "literal": "it", "code": "IT", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:d57c574b-0514-49a7-8e38-11365c287d4e", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "TUMORE DEL PANCREAS, DARAXONRASIB NON ANCORA DISPONIBILE IN ITALIA. AIOM: “SIA AVVIATO SUBITO IL PROGRAMMA DI USO COMPASSIONEVOLE”", "description_text": "Tumore del pancreas, AIOM: daraxonrasib non è disponibile in Italia, avviare subito l'uso compassionevole", "copyrightholder": "nbg1.your-objectstorage.com", "copyrightnotice": "Wireva desk", "usageterms": "Supplied with the copy; origin to be confirmed by the desk before redistribution.", "altids": {"wireva": "d57c574b-0514-49a7-8e38-11365c287d4e"}, "extra": {"wireva:delivery_mode": "preview_and_link", "wireva:rights": {"licence": "Desk-supplied", "licence_url": "", "licence_raw": "Manual upload", "licence_verified_at": "2026-10-08T10:39:59.013139Z", "attribution_required": true, "attribution_text": "Wireva desk", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "nbg1.your-objectstorage.com", "source_url": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-140-IT-2.jpg", "source_page_url": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-140-IT-2.jpg", "our_page_url": "https://ascensio.uno/societa/tumore-del-pancreas-aiom-chiede-l-uso-compassionevole-del-daraxonrasib/"}, "wireva:role": "lead"}, "renditions": {"preview": {"href": "https://nbg1.your-objectstorage.com/ckln/image-assets/16a03b26f1f1c0a505a4938a9844421162ad30c0eeff1af2da0cfd5d590295e5.jpg", "mimetype": "image/jpeg", "width": 244, "height": 206}, "source": {"href": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-140-IT-2.jpg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:6739b234-ac65-483b-bb06-337750f8d620", "slug": "tumore-del-pancreas-aiom-daraxonrasib-non-e-disponibile-in-italia-avviare-subito-luso-compassionevole-20261008", "status": "updated", "languages": ["it"], "item_count": 2, "is_breaking": false}, "wireva:rights": {"class": "owned", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Ascensio", "canonical_required": true, "canonical_url": "https://ascensio.uno/societa/tumore-del-pancreas-aiom-chiede-l-uso-compassionevole-del-daraxonrasib/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "own_production", "needs_review": false}, "wireva:provenance": {"production_method": "ai_assisted", "ai_stages": {"editing": true, "drafting": true, "headline": true, "image_selection": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "unverified", "independent_confirmations": 0, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "Questo articolo è stato prodotto con l’ausilio dell’IA sotto la responsabilità editoriale di Haydamax OÜ.", "independence_check": {"status": "not_applicable", "score": 0.0, "checked_at": "2026-10-08T10:39:59.010160Z"}}, "wireva:publication": {"name": "Ascensio", "domain": "ascensio.uno", "country": "IT", "url": "https://ascensio.uno/societa/tumore-del-pancreas-aiom-chiede-l-uso-compassionevole-del-daraxonrasib/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/d4db6a48-e521-4ba5-8c8a-e7bcee1c647a", "html": "https://wireva.mib.news/item/d4db6a48-e521-4ba5-8c8a-e7bcee1c647a/tumore-del-pancreas-aiom-chiede-l-uso-compassionevole-del-daraxonrasib/", "story": "https://wireva.mib.news/story/tumore-del-pancreas-aiom-daraxonrasib-non-e-disponibile-in-italia-avviare-subito-luso-compassionevole-20261008/"}, "wireva:metrics": {"word_count": 413, "char_count": 2855, "reading_time_seconds": 204}}}